Lifecore Biomedical, Inc.
LFCRNASDAQHealthcare● Active
$5.58
$-0.06(-0.98%)
Market Cap$209114944
P/E Ratio—
52W High$8.98
52W Low$3.63
Lifecore Biomedical, Inc. (LFCR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · LFCR · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-05 | 2024-05 | 2023-05 | 2022-05 | 2021-05 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.13B | $0.13B | $0.10B | $0.11B | $0.10B |
| Cost of Revenue | $0.09B | $0.09B | $0.08B | $0.07B | $0.06B |
| Gross Profit | $0.04B | $0.04B | $0.03B | $0.04B | $0.04B |
| Gross Margin %(computed) | 31.27% | 32.63% | 27.10% | 35.11% | 38.60% |
| Operating Expenses | |||||
| R&D Expenses | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.06B | $0.05B | $0.05B | $0.05B | $0.05B |
| Operating Income | ($0.02B) | ($0.01B) | ($0.02B) | ($0.01B) | ($0.01B) |
| Operating Margin %(computed) | -13.38% | -6.90% | -21.11% | -10.60% | -8.75% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.02B | $0.02B | $0.02B | $0.02B | $0.01B |
| Income Before Tax | ($0.04B) | $0.01B | ($0.06B) | ($0.02B) | ($0.03B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | ($0.01B) | ($0.01B) |
| Net Income | ($0.04B) | $0.01B | ($0.10B) | ($0.12B) | ($0.03B) |
| Net Margin %(computed) | -30.04% | 9.37% | -96.41% | -104.89% | -32.01% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.27 | $0.39 | $-3.32 | $-3.97 | $-1.12 |
| Wtd Avg Shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| EBITDA | ($0.01B) | $0.04B | ($0.03B) | $0.01B | ($0.00B) |
| EBITDA Margin %(computed) | -6.84% | 27.76% | -32.12% | 11.54% | -0.98% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Lifecore Biomedical, Inc. data
About Lifecore Biomedical, Inc. (LFCR) Income Statement
Lifecore Biomedical, Inc. (LFCR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, LFCR reported revenue of $0.13B, gross profit of $0.04B (gross margin 31.27%), and net income of ($0.04B) — a net profit margin of -30.04%.
Frequently asked questions
LFCR · 4 questionsLifecore Biomedical, Inc. (LFCR) reported revenue of $0.13B for 2025, up 0.5% year-over-year.
LFCR revenueLFCR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08